发明名称 |
EXO-S-MECAMYLAMINE FORMULATION AND USE IN TREATMENT |
摘要 |
<P>PROBLEM TO BE SOLVED: To provide a treatment for a nicotine reactive neuropsycological disturbance including administration of a pharmaceutically effective dose of exo-S-mecamylamine (a nicotine antagonist) or a pharmaceutically allowable salt of the same substantially free from exo-R-mecamylamine. <P>SOLUTION: A pharmaceutical composition for the nicotine reactive neuropsychiatric disorders includes a pharmaceutically effective dose of exo-S-mecamylamine (a nicotine antagonist) or a pharmaceutically allowable salt of the same substantially free from exo-R-mecamylamine in combination with a pharmaceutically allowable carrier. The preferred pharmaceutically effective dose of the agent is about 0.5 mg to about 20 mg. <P>COPYRIGHT: (C)2011,JPO&INPIT |
申请公布号 |
JP2011126909(A) |
申请公布日期 |
2011.06.30 |
申请号 |
JP20110055716 |
申请日期 |
2011.03.14 |
申请人 |
UNIV OF SOUTH FLORIDA |
发明人 |
SHYTLE DOUGLAS;SANBERG PAUL;NEWMAN MARY;SILVER ARCHIE |
分类号 |
A61K9/06;A61K31/13;A01N33/02;A01N33/18;A01N33/24;A61K9/08;A61K9/22;A61K9/52;A61K31/015;A61P1/04;A61P1/06;A61P3/02;A61P9/12;A61P25/02;A61P25/14;A61P25/16;A61P25/18;A61P25/22;A61P25/24;A61P25/28;A61P25/30;A61P25/32;A61P25/34;A61P35/00;A61P37/08;C07C209/88;C07C211/34;C07D217/26 |
主分类号 |
A61K9/06 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|